Search results for the

In early 2017, the HCPC commenced a review of the Indicative Sanctions Policy to ensure it is up to date, reflects public opinion, and continues to support fair and proportionate decision making. As part of this review we commissioned market research into the public’s views of the Policy and undertook a public consultation.

A 45 minute session designed to help you define various forms of sexual misconduct and the impact of sexual misconduct in the workplace.

We are undertaking a review of the standards of education and training (SETs).

Continuing professional development (CPD) should improve your work and have a positive impact for your service users

We understand that employers and managers often want to provide guidance and support to employees who are going through the fitness to practise process

Statistical summary of the HCPC Register, including the number of registrants by profession, age profile and working location.

The HCPC has responded in support of the Government Equalities Office (GEO) consultation proposing a ban on practices known as conversion therapy in England and Wales.

Professional bodies typically promote the profession, represent their members and provide curriculum frameworks, training and CPD.

Today we have launched a consultation which outlines proposed changes to the Standards of conduct, performance and ethics.

Our priority is ensuring that registrants have access to advice and support, so that they can get the help they need and ensure they are able to continue to practise safely, without fear of the impact on their registration. To support this, we have produced online materials aimed at registrants and updated our guidance on health and character to include more illustrative case studies.

You can use your online account to request that your name is changed on the HCPC Register

We required that all education providers embedded our revised standards of proficiency (SOPs) from September 2023. We have assessed education provider alignment with the SOPs, and have considered common practices and challenges with this alignment.

From midnight on 1st April 2019, gabapentin and pregabalin will be reclassified as Schedule 3 controlled drugs, under the Misuse of Drugs Regulations (2001), and Class C of the Misuse of Drugs Act (1971)

Find out who won the HCPC student competition 2023, which asked students to design a learning session about health and wellbeing.